Benzinga's Top Initiations

Analysts at Stifel Nicolaus initiated coverage of

with a Buy rating. CIGNA shares fell 4.40 percent to close at $122.09 on Monday. Baird initiated coverage of

with a Outperform rating. Karyopharm Therapeutics shares tumbled 10.11 percent to close at $6.76 on Monday. JP Morgan initiated coverage on

with a Underweight rating. Brown & Brown shares dropped 2.22 percent to close at $34.82 on Monday. Analysts at Bank of America initiated coverage on

with a Buy rating. Ultragenyx Pharmaceutical shares declined 3.88 percent to close at $47.26 on Monday. Analysts at Summit Redstone Partners initiated coverage on

with a Buy rating. RingCentral shares dropped 4.05 percent to close at $19.21 on Monday. Analysts at Rodman & Renshaw initiated coverage on

with a Buy rating. The target price for Neurometrix is set to $4.50. Neurometrix shares closed at $1.73 on Monday. Analysts at Canaccord Genuity initiated coverage of

with a Hold rating. The target price for Monogram Residential Trust is set to $11. Monogram Residential Trust shares rose 0.77 percent to close at $9.86 on Monday. Analysts at National Securities initiated coverage on

with a Neutral rating. Ares Capital shares rose 0.72 percent to $13.97 in pre-market trading.